270 related articles for article (PubMed ID: 16571615)
1. Cost-optimisation of screening for latent tuberculosis in close contacts.
Diel R; Nienhaus A; Lange C; Schaberg T
Eur Respir J; 2006 Jul; 28(1):35-44. PubMed ID: 16571615
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.
Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T
Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
Oxlade O; Schwartzman K; Menzies D
Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
Diel R; Nienhaus A; Loddenkemper R
Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.
Lee SS; Liu YC; Huang TS; Chen YS; Tsai HC; Wann SR; Lin HH
Scand J Infect Dis; 2008; 40(5):373-80. PubMed ID: 18418798
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan.
Kowada A; Takahashi O; Shimbo T; Ohde S; Tokuda Y; Fukui T
Mol Diagn Ther; 2008; 12(4):235-51. PubMed ID: 18652520
[TBL] [Abstract][Full Text] [Related]
10. Direct costs of three models for the screening of latent tuberculosis infection.
Wrighton-Smith P; Zellweger JP
Eur Respir J; 2006 Jul; 28(1):45-50. PubMed ID: 16611659
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
Kowada A
Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
[TBL] [Abstract][Full Text] [Related]
12. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
[TBL] [Abstract][Full Text] [Related]
13. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany.
Diel R; Schaberg T; Loddenkemper R; Welte T; Nienhaus A
Respir Med; 2009 Dec; 103(12):1838-53. PubMed ID: 19682884
[TBL] [Abstract][Full Text] [Related]
15. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
Diel R; Wrighton-Smith P; Zellweger JP
Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
[TBL] [Abstract][Full Text] [Related]
19. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]